Lyell Immunopharma, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 0.065 million compared to USD 0.553 million a year ago. Net loss was USD 66.96 million compared to USD 68.14 million a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.605 USD | +2.56% | +4.00% | +34.02% |
06/05 | Sector Update: Health Care Stocks Higher in Late Afternoon Trading | MT |
06/05 | Lyell Immunopharma Shares Rise After Q1 Net Loss Narrows | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.02% | 648M | |
+7.42% | 111B | |
+11.26% | 106B | |
-12.71% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.59% | 16.81B | |
+37.40% | 12.54B | |
-23.98% | 8.09B |
- Stock Market
- Equities
- LYEL Stock
- News Lyell Immunopharma, Inc.
- Lyell Immunopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023